Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
NCT: NCT07075159 · COMPLETED
Brief Summary
This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.
Frequently Asked Questions
What is Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing?
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing is a clinical trial registered under NCT07075159. Current status: COMPLETED.
What is the status of NCT07075159?
The current status of NCT07075159 (Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing) is: COMPLETED.
When did Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing start?
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing started on 2025-02-28.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.